All News
Filter News
Found 809,065 articles
-
Takara Bio Selects AGC Biologics as Manufacturer of Plasmid DNA Intermediate for a Vaccine Against COVID-19 (SARS-CoV-2)
5/21/2020
AGC Biologics, a global Contract Development and Manufacturing Organization for Biopharmaceuticals, has announced its partnership with Takara Bio.The companies will partner in the fight against COVID-19 by collaborating on a prophylaxis DNA vaccine, with AGC Biologics manufacturing the plasmid DNA intermediate for the vaccine.
-
Cipla Receives Final Approval for Generic Version of Migranal® (Dihydroergotamine Mesylate Nasal Spray 4mg/mL) With a Competitive Generic Therapy Designation
5/21/2020
Cipla Limited announced that it has received final approval for its Abbreviated New Drug Application for Dihydroergotamine Mesylate Nasal Spray 4mg/mL from the United States Food and Drug Administration with a Competitive Generic Therapy designation.
-
PathSpot Raises $6.5 Million in Series A Financing
5/21/2020
Hand hygiene management system protects against the threat and spread of illness with a hand scanner that tracks handwashing frequency and effectiveness
-
Sensorion Publishes Results of General Assembly Resolutions - May 21, 2020
5/21/2020
Sensorion a pioneering clinical-stage biotech company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, has announced the results of resolutions presented at its General Assembly on May 20, 2020 and made them available on the dedicated section of its website.
-
Can QR codes make a difference for children in casts?
5/21/2020
Scannable cast codes prove successful in proactive management of potential cast problems [21-May-2020] ROSEMONT, Ill. , May 21, 2020 /PRNewswire/ -- When children require a cast due to a bone fracture, follow-up care instructions are typically given verbally or the patient is sent home with written instructions. However, patients and their caregivers run the risk of f
-
100+ Experts Identified Top Threats and Opportunities for Global Health Just Before COVID-19 Emerged as the First Test of the Medicines Supply Chain
5/21/2020
New U.S. Pharmacopeia and MIT Center for Collective Intelligence report examines outlook for the future of medical breakthroughs.
-
CVS Health Expands Statewide COVID-19 Response By Opening 16 Additional New Drive-Thru Test Sites in Arizona
5/21/2020
In an ongoing effort to help slow the spread of the virus, CVS Health expanded its COVID-19 testing program by announcing 16 additional test sites at select CVS Pharmacy drive-thru locations across Arizona.
-
Atrion Corporation Declares Quarterly Cash Dividend payable on June 30, 2020
5/21/2020
Atrion Corporation announced that its Board of Directors declared a quarterly dividend of $1.55 per share on its outstanding shares of Common Stock.
-
HealthWell Foundation Confirms Commitment to Hepatitis C Patients During Hepatitis Awareness Month
5/21/2020
The HealthWell Foundation®, an independent non-profit that provides a financial lifeline for inadequately insured Americans, reaffirms its commitment to supporting the Hepatitis C community during Hepatitis Awareness Month and for the long-term by offering financial assistance to eligible patients living with hepatitis C.
-
High Calibre Additions to the Juvenescence Team
5/21/2020
Juvenescence Limited, a life sciences company focused on modifying aging and increasing human longevity, is pleased to announce the appointment of Dr. Jean-Christophe Renondin to its Main Board of Directors, and of Dr. David Roblin and Dr. Steve Felstead to its Senior Leadership Team.
-
ContraFect Corporation Announces Proposed Public Offering of Common Stock and Warrants
5/21/2020
ContraFect Corporation, a clinical-stage biotechnology company focused on discovering and developing direct lytic agents for the treatment of life-threatening infectious diseases, announced that it has commenced an underwritten public offering of shares of its common stock and warrants to purchase additional shares of its common stock.
-
Akorn to Use Voluntary Chapter 11 Process to Position Business for Long-Term Success
5/21/2020
Continues Operations as Usual, Delivering Safe and Effective Products to Customers and Patients
-
Nation's Largest Kidney Patient and Professional Organizations Urge Action to Protect Patients During Reopening
5/21/2020
The National Kidney Foundation and American Society of Nephrology join to advance the unique needs of kidney patients during COVID-19
-
Satya Chauhan Named Battelle Inventor of the Year
5/21/2020
Battelle has honored Satya Chauhan as its Inventor of the Year and Kavitha Dasu as its most recent Emerging Scientist.
-
BioLargo Subsidiary Clyra Medical’s Clyraguard Product Shows Complete Inactivation of SARS-CoV-2 Virus in Galveston National Lab Study
5/21/2020
BioLargo, Inc. announced that Clyraguard, the product developed by its partially owned subsidiary Clyra Medical Technologies in response to the COVID-19 pandemic has been successfully shown to cause complete inactivation of the SARS-CoV-2 virus in laboratory testing.
-
Prestigious Klee Family Foundation Prize 2020 Awarded for Outstanding Scientific Work Identifying Patient-Specific Approach as Better Way to Optimize Knee Implant Design
5/21/2020
Dr. Malte Asseln awarded annual prize by German Society for Biomedical Engineering at the VDE Association and the Klee Family Foundation for his scientific computer-and-image-based workflow to optimize knee implant design
-
Avantor® Announces Pricing of Secondary Offering - May 21, 2020
5/21/2020
Avantor, Inc. announced the pricing of the previously announced underwritten secondary offering of 45,000,000 shares of the Company's common stock held by certain of its stockholders pursuant to a registration statement filed by the Company with the U.S. Securities and Exchange Commission, at the public offering price of $16.25 per share.
-
scPharmaceuticals Announces Pricing of Public Offering of Common Stock - May 21, 2020
5/21/2020
scPharmaceuticals Inc. announced the pricing of an underwritten public offering of 5,780,347 shares of its common stock at a public offering price of $8.65 per share, before deducting underwriting discounts and commissions and other offering expenses, for gross proceeds of approximately $50.0 million.
-
Accreditation Council for Medical Affairs launches accredited Prior Authorization Certified Specialist program
5/21/2020
The Accreditation Council for Medical Affairs, an organization exclusively dedicated to raising industry standards surrounding medical affairs has announced a newly accredited professional certification called the Prior Authorization Certified Specialist program.
-
Mymetics and Baylor College of Medicine start Research Collaboration for Virosome-based Covid-19 Vaccines
5/21/2020
Mymetics Corporation announced that its subsidiary, Mymetics BV, has signed a Research Collaboration Agreement with Baylor College of Medicine and Texas Children's Center for Vaccine Development for evaluating their rationally designed recombinant protein-based SARS-CoV and SARS-CoV-2 antigens and combining them with Mymetics' virosomes for the development of a safe and effective Covid-19 vaccine.